Fact check · Version 1 · Sources checked
“Retatrutide caused weight loss in a randomized human trial.”
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Supported with scope
The reviewed evidence supports this exact statement only in the situation described below.
The phase 2 trial reported dose-dependent weight reduction over 48 weeks in a defined adult population.
- What this answer is based on
- This answer uses a study that assigned people to groups by chance and measured a health outcome.
- Limits of this answer
- Adults meeting the phase 2 obesity-trial criteria over 48 weeks. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
- Topic
- What a study measured about people's health, symptoms, or ability to function.
Sources for this fact check
- Sources checked by
- Site editor · Editorial review